Eli Lilly 주식 가격. LLY - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

27.06

매수가

27.00

매도가

27.75

거래량

110,601

27.00 일간 변동폭 28.00

0.00 52주 범위 0.00

전일 종가

28.24

개장가

27.94

최근 거래 시간

27.06

마지막 거래 시간

평균 볼륨(3m)

재정 규모

VWAP

FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease

FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease PR Newswire INDIANAPOLIS, Jan. 15, 2025 In the pivotal...

Form 8-K - Current report

Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance

Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance PR Newswire INDIANAPOLIS, Jan. 14, 2025 2024 revenue is expected to be approximately $45.0 billion for the full...

Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program

Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program PR Newswire INDIANAPOLIS and BOSTON, Mass., Jan. 13, 2025 The acquisition will expand Lilly's oncology pipeline...

Lilly to participate in J.P. Morgan Healthcare Conference

Lilly to participate in J.P. Morgan Healthcare Conference PR Newswire INDIANAPOLIS, Jan. 7, 2025 INDIANAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will attend the 43rd...

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity PR Newswire INDIANAPOLIS, Dec. 20, 2024...

Lilly's Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's Disease

Lilly's Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's Disease PR Newswire INDIANAPOLIS, Dec. 17, 2024 China is the fourth major market where...

Form 4 - Statement of changes in beneficial ownership of securities

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

LLY - Frequently Asked Questions (FAQ)

What is the current Eli Lilly share price?

The current share price of Eli Lilly is $ 27.06

What is the 1 year trading range for Eli Lilly share price?

Eli Lilly has traded in the range of $ 0.00 to $ 0.00 during the past year

가장 활성
% 상승자
% 패자

기호	가격	볼륨
HOLDImmutable Holdings Inc	$ 0.15 (15.38%)	712.21k
MLCMount Logan Capital Inc	$ 2.88 (14.29%)	33.25k
FHFilament Health Corp	$ 0.04 (14.29%)	155.09k
IFSSInterfield Global Software Inc	$ 0.045 (12.50%)	1,000
ALGOLight AI Inc	0.81 (9.46%)	1.01M
CDMNCanadian Manganese Company Inc	$ 0.03 (-14.29%)	183.94k
BTQBTQ Technologies Corp	$ 3.63 (-12.95%)	527k
MOLYGreenland Resources Inc	$ 0.86 (-9.47%)	476.4k
NETZCarbon Streaming Corporation WTS B	$ 0.53 (-5.36%)	31k
INXDINX Digital Company Inc	$ 0.09 (-5.26%)	23.5k
ALGOLight AI Inc	0.81 (9.46%)	1.01M
VERSVerses AI Inc	$ 2.17 (3.83%)	992.8k
DEFIValour Inc	$ 4.59 (3.61%)	833.56k
CBSTCannabist Company Holdings Inc	$ 0.105 (0.00%)	796.48k
HOLDImmutable Holdings Inc	$ 0.15 (15.38%)	712.21k